Literature DB >> 7075408

Circulating CEA levels in patients with fulminant hepatitis.

P K George, M S Loewenstein, M J O'Brien, B Bronstein, R S Koff, N Zamcheck.   

Abstract

CEA levels were determined in blood specimens from 14 persons suffering from fulminant hepatitis. Values ranged from 1.9 to 21 ng/ml with a mean of 7.0 ng/ml. All except one patient had a CEA level greater than 2.5 ng/ml, but only three exceeded 10 ng/ml. There was no correlation between single CEA levels and prognosis, routine liver chemistries, or histopathologic characterization of hepatic tissue obtained at postmortem examination. These data show that patients with fulminant hepatitis commonly had increased circulating levels of CEA, but these elevations were far less than may be found in patients with hepatic metastases. In severe hepatic dysfunction reduced hepatic clearance of CEA may be responsible for the increased levels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075408     DOI: 10.1007/bf01311707

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  The hepatic clearance of circulating native and asialo carcinoembronic antigen by the rat.

Authors:  P Thomas; D A Hems
Journal:  Biochem Biophys Res Commun       Date:  1975-12-01       Impact factor: 3.575

2.  The disparity of indirect and direct zirconyl-gel assays for carcinoembryonic antigen.

Authors:  H Z Kupchik; M S Loewenstein; M Feil; R A Rittgers; N Zamcheck
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

3.  Diagnostic usefulness of plasma carcinoembryonic antigen levels in acute and chronic liver disease.

Authors:  A W Bullen; M S Losowsky; S Carter; S Patel; A M Neville
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

4.  Metastatic carcinoma presenting as fulminant hepatic failure.

Authors:  E A Krauss; P W Ludwig; H W Sumner
Journal:  Am J Gastroenterol       Date:  1979-12       Impact factor: 10.864

5.  Multifocal malignant hemangioendothelioma presenting as acute hepatitis. A clinicopathologic study.

Authors:  A M Stein; K Fawaz; A Tabrizi; R Blanchard; S Hou
Journal:  Am J Gastroenterol       Date:  1977-04       Impact factor: 10.864

6.  Studies on the mechanisms of biliary excretion of circulating glycoproteins. The carcinoembryonic antigen.

Authors:  P Thomas
Journal:  Biochem J       Date:  1980-12-15       Impact factor: 3.857

7.  Carcinoembryonic antigen: transmission by blood products.

Authors:  G L Gitnick; I G Molnar
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

8.  Localized submassive liver cell necrosis as a terminal event of liver carcinoma.

Authors:  K Okuda; H Musha; H Kanno; M Igarashi; M Nakano
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

9.  Elevated carcinoembryonic antigen levels and biliary tract obstruction.

Authors:  B B Lurie; M S Loewenstein; N Zamcheck
Journal:  JAMA       Date:  1975-07-28       Impact factor: 56.272

10.  Carcinoembryonic antigen in serum in diseases of the liver and pancreas.

Authors:  S K Khoo; I R Mackay
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

View more
  5 in total

Review 1.  Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.

Authors:  Helena J Janse van Rensburg; Pavlina Spiliopoulou; Lillian L Siu
Journal:  Oncologist       Date:  2022-05-06       Impact factor: 5.837

2.  Cardiac failure, hepatic congestion and increased level of serum carcinoembryonic antigen.

Authors:  A Pönkä; T Forslund
Journal:  Postgrad Med J       Date:  1984-01       Impact factor: 2.401

3.  Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.

Authors:  Hanna Nyström; Björn Tavelin; Moa Björklund; Peter Naredi; Malin Sund
Journal:  Tumour Biol       Date:  2015-07-11

4.  Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C.

Authors:  Mehdi Assmar; Sara Yeganeh; Fariborz Mansourghanaei; Nour Amirmozafari
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

5.  Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer.

Authors:  Leilani Lakemeyer; Silvia Sander; Mathias Wittau; Doris Henne-Bruns; Marko Kornmann; Johannes Lemke
Journal:  Diseases       Date:  2021-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.